3APS

DRUG2 trials

Sponsors

Bellus Health Inc. - a GSK company

Conditions

Alzheimer DiseaseAlzheimer's Disease

Phase 3

Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

Bellus Health Inc. - a GSK companyAlzheimer Disease

Start: 2004-06-30Target: 950Updated: 2007-02-28

European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients

Bellus Health Inc. - a GSK companyAlzheimer's Disease

Start: 2005-09-30End: 2007-12-31Target: 930Updated: 2007-12-10